nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—UGT1A9—Irinotecan—stomach cancer	0.226	0.402	CbGbCtD
Tapentadol—UGT2B7—Epirubicin—stomach cancer	0.219	0.391	CbGbCtD
Tapentadol—CYP2C9—Capecitabine—stomach cancer	0.061	0.109	CbGbCtD
Tapentadol—CYP2C9—Fluorouracil—stomach cancer	0.0362	0.0645	CbGbCtD
Tapentadol—HTR3A—myenteric nerve plexus—stomach cancer	0.0267	0.301	CbGeAlD
Tapentadol—CYP2D6—Doxorubicin—stomach cancer	0.0188	0.0336	CbGbCtD
Tapentadol—HTR3A—vagus nerve—stomach cancer	0.0178	0.201	CbGeAlD
Tapentadol—UGT1A9—digestive system—stomach cancer	0.00344	0.0388	CbGeAlD
Tapentadol—HTR3A—hematopoietic system—stomach cancer	0.00291	0.0328	CbGeAlD
Tapentadol—UGT1A9—endocrine gland—stomach cancer	0.00284	0.0321	CbGeAlD
Tapentadol—UGT2B7—digestive system—stomach cancer	0.00277	0.0313	CbGeAlD
Tapentadol—OPRM1—hematopoietic system—stomach cancer	0.00267	0.0301	CbGeAlD
Tapentadol—UGT1A9—liver—stomach cancer	0.00256	0.0289	CbGeAlD
Tapentadol—UGT2B7—endocrine gland—stomach cancer	0.00229	0.0258	CbGeAlD
Tapentadol—SLC6A4—hematopoietic system—stomach cancer	0.00222	0.025	CbGeAlD
Tapentadol—UGT2B7—liver—stomach cancer	0.00207	0.0233	CbGeAlD
Tapentadol—HTR3A—digestive system—stomach cancer	0.00202	0.0228	CbGeAlD
Tapentadol—CYP2C19—hematopoietic system—stomach cancer	0.00184	0.0207	CbGeAlD
Tapentadol—SLC6A4—digestive system—stomach cancer	0.00154	0.0174	CbGeAlD
Tapentadol—OPRM1—endocrine gland—stomach cancer	0.00153	0.0173	CbGeAlD
Tapentadol—CYP2C9—hematopoietic system—stomach cancer	0.00142	0.0161	CbGeAlD
Tapentadol—CYP2C19—digestive system—stomach cancer	0.00128	0.0144	CbGeAlD
Tapentadol—SLC6A4—endocrine gland—stomach cancer	0.00127	0.0144	CbGeAlD
Tapentadol—SLC6A2—endocrine gland—stomach cancer	0.00112	0.0127	CbGeAlD
Tapentadol—CYP2D6—hematopoietic system—stomach cancer	0.00107	0.0121	CbGeAlD
Tapentadol—CYP2C19—endocrine gland—stomach cancer	0.00106	0.0119	CbGeAlD
Tapentadol—CYP2C9—digestive system—stomach cancer	0.000991	0.0112	CbGeAlD
Tapentadol—CYP2C19—liver—stomach cancer	0.000952	0.0107	CbGeAlD
Tapentadol—CYP2C9—endocrine gland—stomach cancer	0.000819	0.00924	CbGeAlD
Tapentadol—SLC6A2—lymph node—stomach cancer	0.000776	0.00875	CbGeAlD
Tapentadol—CYP2D6—digestive system—stomach cancer	0.000743	0.00839	CbGeAlD
Tapentadol—CYP2C9—liver—stomach cancer	0.000738	0.00833	CbGeAlD
Tapentadol—CYP2D6—endocrine gland—stomach cancer	0.000614	0.00693	CbGeAlD
Tapentadol—CYP2D6—liver—stomach cancer	0.000554	0.00625	CbGeAlD
Tapentadol—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.00035	0.00146	CcSEcCtD
Tapentadol—Pollakiuria—Doxorubicin—stomach cancer	0.000348	0.00145	CcSEcCtD
Tapentadol—Arthralgia—Capecitabine—stomach cancer	0.000346	0.00144	CcSEcCtD
Tapentadol—Confusional state—Docetaxel—stomach cancer	0.000346	0.00144	CcSEcCtD
Tapentadol—Anxiety—Capecitabine—stomach cancer	0.000345	0.00144	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000344	0.00143	CcSEcCtD
Tapentadol—Urinary tract disorder—Methotrexate—stomach cancer	0.000343	0.00143	CcSEcCtD
Tapentadol—Anaphylactic shock—Docetaxel—stomach cancer	0.000343	0.00143	CcSEcCtD
Tapentadol—Oedema—Docetaxel—stomach cancer	0.000343	0.00143	CcSEcCtD
Tapentadol—Urethral disorder—Methotrexate—stomach cancer	0.000341	0.00142	CcSEcCtD
Tapentadol—Infection—Docetaxel—stomach cancer	0.000341	0.00142	CcSEcCtD
Tapentadol—Weight decreased—Doxorubicin—stomach cancer	0.00034	0.00142	CcSEcCtD
Tapentadol—Diarrhoea—Irinotecan—stomach cancer	0.000339	0.00141	CcSEcCtD
Tapentadol—Dry mouth—Capecitabine—stomach cancer	0.000339	0.00141	CcSEcCtD
Tapentadol—Shock—Docetaxel—stomach cancer	0.000337	0.00141	CcSEcCtD
Tapentadol—Nervous system disorder—Docetaxel—stomach cancer	0.000336	0.0014	CcSEcCtD
Tapentadol—Pruritus—Fluorouracil—stomach cancer	0.000336	0.0014	CcSEcCtD
Tapentadol—Infestation NOS—Doxorubicin—stomach cancer	0.000335	0.0014	CcSEcCtD
Tapentadol—Infestation—Doxorubicin—stomach cancer	0.000335	0.0014	CcSEcCtD
Tapentadol—Visual impairment—Methotrexate—stomach cancer	0.000335	0.0014	CcSEcCtD
Tapentadol—Confusional state—Capecitabine—stomach cancer	0.000335	0.00139	CcSEcCtD
Tapentadol—Tachycardia—Docetaxel—stomach cancer	0.000335	0.00139	CcSEcCtD
Tapentadol—Skin disorder—Docetaxel—stomach cancer	0.000333	0.00139	CcSEcCtD
Tapentadol—Oedema—Capecitabine—stomach cancer	0.000332	0.00138	CcSEcCtD
Tapentadol—Bradycardia—Epirubicin—stomach cancer	0.000331	0.00138	CcSEcCtD
Tapentadol—Infection—Capecitabine—stomach cancer	0.00033	0.00137	CcSEcCtD
Tapentadol—Dizziness—Irinotecan—stomach cancer	0.000328	0.00137	CcSEcCtD
Tapentadol—Shock—Capecitabine—stomach cancer	0.000327	0.00136	CcSEcCtD
Tapentadol—Urinary tract infection—Doxorubicin—stomach cancer	0.000326	0.00136	CcSEcCtD
Tapentadol—Nervous system disorder—Capecitabine—stomach cancer	0.000326	0.00136	CcSEcCtD
Tapentadol—Eye disorder—Methotrexate—stomach cancer	0.000325	0.00135	CcSEcCtD
Tapentadol—Diarrhoea—Fluorouracil—stomach cancer	0.000325	0.00135	CcSEcCtD
Tapentadol—Tachycardia—Capecitabine—stomach cancer	0.000324	0.00135	CcSEcCtD
Tapentadol—Hypoaesthesia—Epirubicin—stomach cancer	0.000324	0.00135	CcSEcCtD
Tapentadol—Cardiac disorder—Methotrexate—stomach cancer	0.000323	0.00135	CcSEcCtD
Tapentadol—Skin disorder—Capecitabine—stomach cancer	0.000322	0.00134	CcSEcCtD
Tapentadol—Urinary tract disorder—Epirubicin—stomach cancer	0.000321	0.00134	CcSEcCtD
Tapentadol—Hyperhidrosis—Capecitabine—stomach cancer	0.000321	0.00134	CcSEcCtD
Tapentadol—Hypotension—Docetaxel—stomach cancer	0.00032	0.00134	CcSEcCtD
Tapentadol—Connective tissue disorder—Epirubicin—stomach cancer	0.00032	0.00133	CcSEcCtD
Tapentadol—Urethral disorder—Epirubicin—stomach cancer	0.000319	0.00133	CcSEcCtD
Tapentadol—Angiopathy—Methotrexate—stomach cancer	0.000316	0.00132	CcSEcCtD
Tapentadol—Vomiting—Irinotecan—stomach cancer	0.000315	0.00131	CcSEcCtD
Tapentadol—Immune system disorder—Methotrexate—stomach cancer	0.000314	0.00131	CcSEcCtD
Tapentadol—Dizziness—Fluorouracil—stomach cancer	0.000314	0.00131	CcSEcCtD
Tapentadol—Visual impairment—Epirubicin—stomach cancer	0.000314	0.00131	CcSEcCtD
Tapentadol—Mediastinal disorder—Methotrexate—stomach cancer	0.000313	0.00131	CcSEcCtD
Tapentadol—Rash—Irinotecan—stomach cancer	0.000313	0.0013	CcSEcCtD
Tapentadol—Dermatitis—Irinotecan—stomach cancer	0.000312	0.0013	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000312	0.0013	CcSEcCtD
Tapentadol—Chills—Methotrexate—stomach cancer	0.000312	0.0013	CcSEcCtD
Tapentadol—Headache—Irinotecan—stomach cancer	0.000311	0.00129	CcSEcCtD
Tapentadol—Hypotension—Capecitabine—stomach cancer	0.00031	0.00129	CcSEcCtD
Tapentadol—Insomnia—Docetaxel—stomach cancer	0.00031	0.00129	CcSEcCtD
Tapentadol—Paraesthesia—Docetaxel—stomach cancer	0.000308	0.00128	CcSEcCtD
Tapentadol—Bradycardia—Doxorubicin—stomach cancer	0.000307	0.00128	CcSEcCtD
Tapentadol—Dyspnoea—Docetaxel—stomach cancer	0.000306	0.00127	CcSEcCtD
Tapentadol—Somnolence—Docetaxel—stomach cancer	0.000305	0.00127	CcSEcCtD
Tapentadol—Mental disorder—Methotrexate—stomach cancer	0.000305	0.00127	CcSEcCtD
Tapentadol—Eye disorder—Epirubicin—stomach cancer	0.000304	0.00127	CcSEcCtD
Tapentadol—Malnutrition—Methotrexate—stomach cancer	0.000303	0.00126	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000302	0.00126	CcSEcCtD
Tapentadol—Cardiac disorder—Epirubicin—stomach cancer	0.000302	0.00126	CcSEcCtD
Tapentadol—Vomiting—Fluorouracil—stomach cancer	0.000302	0.00126	CcSEcCtD
Tapentadol—Dyspepsia—Docetaxel—stomach cancer	0.000302	0.00126	CcSEcCtD
Tapentadol—Insomnia—Capecitabine—stomach cancer	0.0003	0.00125	CcSEcCtD
Tapentadol—Hypoaesthesia—Doxorubicin—stomach cancer	0.0003	0.00125	CcSEcCtD
Tapentadol—Rash—Fluorouracil—stomach cancer	0.0003	0.00125	CcSEcCtD
Tapentadol—Dermatitis—Fluorouracil—stomach cancer	0.000299	0.00125	CcSEcCtD
Tapentadol—Paraesthesia—Capecitabine—stomach cancer	0.000298	0.00124	CcSEcCtD
Tapentadol—Decreased appetite—Docetaxel—stomach cancer	0.000298	0.00124	CcSEcCtD
Tapentadol—Headache—Fluorouracil—stomach cancer	0.000298	0.00124	CcSEcCtD
Tapentadol—Urinary tract disorder—Doxorubicin—stomach cancer	0.000297	0.00124	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000296	0.00123	CcSEcCtD
Tapentadol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000296	0.00123	CcSEcCtD
Tapentadol—Dyspnoea—Capecitabine—stomach cancer	0.000296	0.00123	CcSEcCtD
Tapentadol—Fatigue—Docetaxel—stomach cancer	0.000296	0.00123	CcSEcCtD
Tapentadol—Angiopathy—Epirubicin—stomach cancer	0.000295	0.00123	CcSEcCtD
Tapentadol—Urethral disorder—Doxorubicin—stomach cancer	0.000295	0.00123	CcSEcCtD
Tapentadol—Nausea—Irinotecan—stomach cancer	0.000295	0.00123	CcSEcCtD
Tapentadol—Immune system disorder—Epirubicin—stomach cancer	0.000294	0.00123	CcSEcCtD
Tapentadol—Mediastinal disorder—Epirubicin—stomach cancer	0.000293	0.00122	CcSEcCtD
Tapentadol—Constipation—Docetaxel—stomach cancer	0.000293	0.00122	CcSEcCtD
Tapentadol—Dyspepsia—Capecitabine—stomach cancer	0.000292	0.00122	CcSEcCtD
Tapentadol—Chills—Epirubicin—stomach cancer	0.000292	0.00122	CcSEcCtD
Tapentadol—Visual impairment—Doxorubicin—stomach cancer	0.00029	0.00121	CcSEcCtD
Tapentadol—Decreased appetite—Capecitabine—stomach cancer	0.000289	0.0012	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000287	0.00119	CcSEcCtD
Tapentadol—Fatigue—Capecitabine—stomach cancer	0.000286	0.00119	CcSEcCtD
Tapentadol—Vision blurred—Methotrexate—stomach cancer	0.000285	0.00119	CcSEcCtD
Tapentadol—Mental disorder—Epirubicin—stomach cancer	0.000285	0.00119	CcSEcCtD
Tapentadol—Constipation—Capecitabine—stomach cancer	0.000284	0.00118	CcSEcCtD
Tapentadol—Malnutrition—Epirubicin—stomach cancer	0.000283	0.00118	CcSEcCtD
Tapentadol—Feeling abnormal—Docetaxel—stomach cancer	0.000283	0.00118	CcSEcCtD
Tapentadol—Nausea—Fluorouracil—stomach cancer	0.000282	0.00118	CcSEcCtD
Tapentadol—Eye disorder—Doxorubicin—stomach cancer	0.000281	0.00117	CcSEcCtD
Tapentadol—Cardiac disorder—Doxorubicin—stomach cancer	0.00028	0.00116	CcSEcCtD
Tapentadol—Tension—Epirubicin—stomach cancer	0.000278	0.00116	CcSEcCtD
Tapentadol—Nervousness—Epirubicin—stomach cancer	0.000275	0.00115	CcSEcCtD
Tapentadol—Feeling abnormal—Capecitabine—stomach cancer	0.000274	0.00114	CcSEcCtD
Tapentadol—Angiopathy—Doxorubicin—stomach cancer	0.000273	0.00114	CcSEcCtD
Tapentadol—Immune system disorder—Doxorubicin—stomach cancer	0.000272	0.00113	CcSEcCtD
Tapentadol—Vertigo—Methotrexate—stomach cancer	0.000272	0.00113	CcSEcCtD
Tapentadol—Mediastinal disorder—Doxorubicin—stomach cancer	0.000271	0.00113	CcSEcCtD
Tapentadol—Chills—Doxorubicin—stomach cancer	0.00027	0.00113	CcSEcCtD
Tapentadol—Vision blurred—Epirubicin—stomach cancer	0.000267	0.00111	CcSEcCtD
Tapentadol—Cough—Methotrexate—stomach cancer	0.000264	0.0011	CcSEcCtD
Tapentadol—Mental disorder—Doxorubicin—stomach cancer	0.000264	0.0011	CcSEcCtD
Tapentadol—Urticaria—Capecitabine—stomach cancer	0.000264	0.0011	CcSEcCtD
Tapentadol—Convulsion—Methotrexate—stomach cancer	0.000262	0.00109	CcSEcCtD
Tapentadol—Malnutrition—Doxorubicin—stomach cancer	0.000262	0.00109	CcSEcCtD
Tapentadol—Agitation—Epirubicin—stomach cancer	0.00026	0.00109	CcSEcCtD
Tapentadol—Arthralgia—Methotrexate—stomach cancer	0.000258	0.00107	CcSEcCtD
Tapentadol—Tension—Doxorubicin—stomach cancer	0.000257	0.00107	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000256	0.00107	CcSEcCtD
Tapentadol—Nervousness—Doxorubicin—stomach cancer	0.000255	0.00106	CcSEcCtD
Tapentadol—Vertigo—Epirubicin—stomach cancer	0.000255	0.00106	CcSEcCtD
Tapentadol—Syncope—Epirubicin—stomach cancer	0.000254	0.00106	CcSEcCtD
Tapentadol—Hypersensitivity—Docetaxel—stomach cancer	0.000253	0.00105	CcSEcCtD
Tapentadol—Palpitations—Epirubicin—stomach cancer	0.00025	0.00104	CcSEcCtD
Tapentadol—Confusional state—Methotrexate—stomach cancer	0.000249	0.00104	CcSEcCtD
Tapentadol—Loss of consciousness—Epirubicin—stomach cancer	0.000249	0.00104	CcSEcCtD
Tapentadol—Cough—Epirubicin—stomach cancer	0.000247	0.00103	CcSEcCtD
Tapentadol—Anaphylactic shock—Methotrexate—stomach cancer	0.000247	0.00103	CcSEcCtD
Tapentadol—Vision blurred—Doxorubicin—stomach cancer	0.000247	0.00103	CcSEcCtD
Tapentadol—Asthenia—Docetaxel—stomach cancer	0.000246	0.00103	CcSEcCtD
Tapentadol—Convulsion—Epirubicin—stomach cancer	0.000246	0.00102	CcSEcCtD
Tapentadol—Infection—Methotrexate—stomach cancer	0.000245	0.00102	CcSEcCtD
Tapentadol—Hypersensitivity—Capecitabine—stomach cancer	0.000245	0.00102	CcSEcCtD
Tapentadol—Pruritus—Docetaxel—stomach cancer	0.000243	0.00101	CcSEcCtD
Tapentadol—Nervous system disorder—Methotrexate—stomach cancer	0.000242	0.00101	CcSEcCtD
Tapentadol—Arthralgia—Epirubicin—stomach cancer	0.000241	0.00101	CcSEcCtD
Tapentadol—Agitation—Doxorubicin—stomach cancer	0.000241	0.001	CcSEcCtD
Tapentadol—Anxiety—Epirubicin—stomach cancer	0.00024	0.001	CcSEcCtD
Tapentadol—Skin disorder—Methotrexate—stomach cancer	0.00024	0.001	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00024	0.000998	CcSEcCtD
Tapentadol—Hyperhidrosis—Methotrexate—stomach cancer	0.000239	0.000996	CcSEcCtD
Tapentadol—Asthenia—Capecitabine—stomach cancer	0.000238	0.000993	CcSEcCtD
Tapentadol—Dry mouth—Epirubicin—stomach cancer	0.000236	0.000983	CcSEcCtD
Tapentadol—Vertigo—Doxorubicin—stomach cancer	0.000236	0.000982	CcSEcCtD
Tapentadol—Syncope—Doxorubicin—stomach cancer	0.000235	0.00098	CcSEcCtD
Tapentadol—Pruritus—Capecitabine—stomach cancer	0.000235	0.000979	CcSEcCtD
Tapentadol—Diarrhoea—Docetaxel—stomach cancer	0.000235	0.000978	CcSEcCtD
Tapentadol—Confusional state—Epirubicin—stomach cancer	0.000233	0.000972	CcSEcCtD
Tapentadol—Palpitations—Doxorubicin—stomach cancer	0.000232	0.000966	CcSEcCtD
Tapentadol—Anaphylactic shock—Epirubicin—stomach cancer	0.000231	0.000964	CcSEcCtD
Tapentadol—Oedema—Epirubicin—stomach cancer	0.000231	0.000964	CcSEcCtD
Tapentadol—Hypotension—Methotrexate—stomach cancer	0.000231	0.000962	CcSEcCtD
Tapentadol—Loss of consciousness—Doxorubicin—stomach cancer	0.00023	0.00096	CcSEcCtD
Tapentadol—Infection—Epirubicin—stomach cancer	0.00023	0.000957	CcSEcCtD
Tapentadol—Cough—Doxorubicin—stomach cancer	0.000229	0.000953	CcSEcCtD
Tapentadol—Shock—Epirubicin—stomach cancer	0.000228	0.000948	CcSEcCtD
Tapentadol—Convulsion—Doxorubicin—stomach cancer	0.000227	0.000947	CcSEcCtD
Tapentadol—Diarrhoea—Capecitabine—stomach cancer	0.000227	0.000947	CcSEcCtD
Tapentadol—Nervous system disorder—Epirubicin—stomach cancer	0.000227	0.000945	CcSEcCtD
Tapentadol—Dizziness—Docetaxel—stomach cancer	0.000227	0.000945	CcSEcCtD
Tapentadol—Tachycardia—Epirubicin—stomach cancer	0.000226	0.000941	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000225	0.000938	CcSEcCtD
Tapentadol—Skin disorder—Epirubicin—stomach cancer	0.000225	0.000936	CcSEcCtD
Tapentadol—Hyperhidrosis—Epirubicin—stomach cancer	0.000224	0.000932	CcSEcCtD
Tapentadol—Insomnia—Methotrexate—stomach cancer	0.000224	0.000931	CcSEcCtD
Tapentadol—Arthralgia—Doxorubicin—stomach cancer	0.000223	0.00093	CcSEcCtD
Tapentadol—Anxiety—Doxorubicin—stomach cancer	0.000222	0.000927	CcSEcCtD
Tapentadol—Paraesthesia—Methotrexate—stomach cancer	0.000222	0.000925	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000222	0.000924	CcSEcCtD
Tapentadol—Dyspnoea—Methotrexate—stomach cancer	0.00022	0.000918	CcSEcCtD
Tapentadol—Somnolence—Methotrexate—stomach cancer	0.00022	0.000916	CcSEcCtD
Tapentadol—Dizziness—Capecitabine—stomach cancer	0.00022	0.000915	CcSEcCtD
Tapentadol—Dry mouth—Doxorubicin—stomach cancer	0.000218	0.00091	CcSEcCtD
Tapentadol—Vomiting—Docetaxel—stomach cancer	0.000218	0.000908	CcSEcCtD
Tapentadol—Dyspepsia—Methotrexate—stomach cancer	0.000218	0.000906	CcSEcCtD
Tapentadol—Rash—Docetaxel—stomach cancer	0.000216	0.000901	CcSEcCtD
Tapentadol—Hypotension—Epirubicin—stomach cancer	0.000216	0.000901	CcSEcCtD
Tapentadol—Dermatitis—Docetaxel—stomach cancer	0.000216	0.0009	CcSEcCtD
Tapentadol—Confusional state—Doxorubicin—stomach cancer	0.000216	0.000899	CcSEcCtD
Tapentadol—Decreased appetite—Methotrexate—stomach cancer	0.000215	0.000895	CcSEcCtD
Tapentadol—Headache—Docetaxel—stomach cancer	0.000215	0.000895	CcSEcCtD
Tapentadol—Anaphylactic shock—Doxorubicin—stomach cancer	0.000214	0.000892	CcSEcCtD
Tapentadol—Oedema—Doxorubicin—stomach cancer	0.000214	0.000892	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000213	0.000889	CcSEcCtD
Tapentadol—Fatigue—Methotrexate—stomach cancer	0.000213	0.000888	CcSEcCtD
Tapentadol—Infection—Doxorubicin—stomach cancer	0.000213	0.000886	CcSEcCtD
Tapentadol—Vomiting—Capecitabine—stomach cancer	0.000211	0.00088	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000211	0.000878	CcSEcCtD
Tapentadol—Shock—Doxorubicin—stomach cancer	0.000211	0.000877	CcSEcCtD
Tapentadol—Nervous system disorder—Doxorubicin—stomach cancer	0.00021	0.000874	CcSEcCtD
Tapentadol—Rash—Capecitabine—stomach cancer	0.000209	0.000872	CcSEcCtD
Tapentadol—Insomnia—Epirubicin—stomach cancer	0.000209	0.000872	CcSEcCtD
Tapentadol—Dermatitis—Capecitabine—stomach cancer	0.000209	0.000871	CcSEcCtD
Tapentadol—Tachycardia—Doxorubicin—stomach cancer	0.000209	0.00087	CcSEcCtD
Tapentadol—Headache—Capecitabine—stomach cancer	0.000208	0.000867	CcSEcCtD
Tapentadol—Skin disorder—Doxorubicin—stomach cancer	0.000208	0.000866	CcSEcCtD
Tapentadol—Paraesthesia—Epirubicin—stomach cancer	0.000208	0.000865	CcSEcCtD
Tapentadol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000207	0.000862	CcSEcCtD
Tapentadol—Dyspnoea—Epirubicin—stomach cancer	0.000206	0.000859	CcSEcCtD
Tapentadol—Somnolence—Epirubicin—stomach cancer	0.000206	0.000857	CcSEcCtD
Tapentadol—Nausea—Docetaxel—stomach cancer	0.000204	0.000849	CcSEcCtD
Tapentadol—Feeling abnormal—Methotrexate—stomach cancer	0.000204	0.000849	CcSEcCtD
Tapentadol—Dyspepsia—Epirubicin—stomach cancer	0.000204	0.000848	CcSEcCtD
Tapentadol—Decreased appetite—Epirubicin—stomach cancer	0.000201	0.000838	CcSEcCtD
Tapentadol—Hypotension—Doxorubicin—stomach cancer	0.0002	0.000833	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.0002	0.000832	CcSEcCtD
Tapentadol—Fatigue—Epirubicin—stomach cancer	0.000199	0.000831	CcSEcCtD
Tapentadol—Constipation—Epirubicin—stomach cancer	0.000198	0.000824	CcSEcCtD
Tapentadol—Nausea—Capecitabine—stomach cancer	0.000197	0.000822	CcSEcCtD
Tapentadol—Urticaria—Methotrexate—stomach cancer	0.000196	0.000818	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000195	0.000812	CcSEcCtD
Tapentadol—Insomnia—Doxorubicin—stomach cancer	0.000194	0.000807	CcSEcCtD
Tapentadol—Paraesthesia—Doxorubicin—stomach cancer	0.000192	0.000801	CcSEcCtD
Tapentadol—Dyspnoea—Doxorubicin—stomach cancer	0.000191	0.000795	CcSEcCtD
Tapentadol—Feeling abnormal—Epirubicin—stomach cancer	0.000191	0.000794	CcSEcCtD
Tapentadol—Somnolence—Doxorubicin—stomach cancer	0.00019	0.000793	CcSEcCtD
Tapentadol—Dyspepsia—Doxorubicin—stomach cancer	0.000188	0.000785	CcSEcCtD
Tapentadol—Decreased appetite—Doxorubicin—stomach cancer	0.000186	0.000775	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000185	0.00077	CcSEcCtD
Tapentadol—Fatigue—Doxorubicin—stomach cancer	0.000184	0.000769	CcSEcCtD
Tapentadol—Urticaria—Epirubicin—stomach cancer	0.000184	0.000766	CcSEcCtD
Tapentadol—Constipation—Doxorubicin—stomach cancer	0.000183	0.000763	CcSEcCtD
Tapentadol—Hypersensitivity—Methotrexate—stomach cancer	0.000182	0.000759	CcSEcCtD
Tapentadol—Asthenia—Methotrexate—stomach cancer	0.000177	0.000739	CcSEcCtD
Tapentadol—Feeling abnormal—Doxorubicin—stomach cancer	0.000176	0.000735	CcSEcCtD
Tapentadol—Pruritus—Methotrexate—stomach cancer	0.000175	0.000729	CcSEcCtD
Tapentadol—Hypersensitivity—Epirubicin—stomach cancer	0.00017	0.00071	CcSEcCtD
Tapentadol—Urticaria—Doxorubicin—stomach cancer	0.00017	0.000708	CcSEcCtD
Tapentadol—Diarrhoea—Methotrexate—stomach cancer	0.000169	0.000705	CcSEcCtD
Tapentadol—Asthenia—Epirubicin—stomach cancer	0.000166	0.000691	CcSEcCtD
Tapentadol—Pruritus—Epirubicin—stomach cancer	0.000164	0.000682	CcSEcCtD
Tapentadol—Dizziness—Methotrexate—stomach cancer	0.000163	0.000681	CcSEcCtD
Tapentadol—Diarrhoea—Epirubicin—stomach cancer	0.000158	0.000659	CcSEcCtD
Tapentadol—Hypersensitivity—Doxorubicin—stomach cancer	0.000158	0.000657	CcSEcCtD
Tapentadol—Vomiting—Methotrexate—stomach cancer	0.000157	0.000655	CcSEcCtD
Tapentadol—Rash—Methotrexate—stomach cancer	0.000156	0.000649	CcSEcCtD
Tapentadol—Dermatitis—Methotrexate—stomach cancer	0.000156	0.000649	CcSEcCtD
Tapentadol—Headache—Methotrexate—stomach cancer	0.000155	0.000645	CcSEcCtD
Tapentadol—Asthenia—Doxorubicin—stomach cancer	0.000154	0.00064	CcSEcCtD
Tapentadol—Dizziness—Epirubicin—stomach cancer	0.000153	0.000637	CcSEcCtD
Tapentadol—Pruritus—Doxorubicin—stomach cancer	0.000151	0.000631	CcSEcCtD
Tapentadol—Vomiting—Epirubicin—stomach cancer	0.000147	0.000613	CcSEcCtD
Tapentadol—Nausea—Methotrexate—stomach cancer	0.000147	0.000612	CcSEcCtD
Tapentadol—Diarrhoea—Doxorubicin—stomach cancer	0.000146	0.00061	CcSEcCtD
Tapentadol—Rash—Epirubicin—stomach cancer	0.000146	0.000608	CcSEcCtD
Tapentadol—Dermatitis—Epirubicin—stomach cancer	0.000146	0.000607	CcSEcCtD
Tapentadol—Headache—Epirubicin—stomach cancer	0.000145	0.000604	CcSEcCtD
Tapentadol—Dizziness—Doxorubicin—stomach cancer	0.000141	0.00059	CcSEcCtD
Tapentadol—Nausea—Epirubicin—stomach cancer	0.000137	0.000572	CcSEcCtD
Tapentadol—Vomiting—Doxorubicin—stomach cancer	0.000136	0.000567	CcSEcCtD
Tapentadol—Rash—Doxorubicin—stomach cancer	0.000135	0.000562	CcSEcCtD
Tapentadol—Dermatitis—Doxorubicin—stomach cancer	0.000135	0.000562	CcSEcCtD
Tapentadol—Headache—Doxorubicin—stomach cancer	0.000134	0.000559	CcSEcCtD
Tapentadol—Nausea—Doxorubicin—stomach cancer	0.000127	0.00053	CcSEcCtD
Tapentadol—UGT1A9—Metabolism—GSTP1—stomach cancer	2.51e-05	0.000227	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—stomach cancer	2.51e-05	0.000227	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FYN—stomach cancer	2.49e-05	0.000225	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PRKCB—stomach cancer	2.47e-05	0.000224	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PPP2R1A—stomach cancer	2.47e-05	0.000224	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—HMOX1—stomach cancer	2.47e-05	0.000224	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6ST—stomach cancer	2.46e-05	0.000223	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—FADS1—stomach cancer	2.42e-05	0.00022	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TYMP—stomach cancer	2.42e-05	0.00022	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PDHA1—stomach cancer	2.37e-05	0.000215	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ECHS1—stomach cancer	2.37e-05	0.000215	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL8—stomach cancer	2.35e-05	0.000213	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PDHA1—stomach cancer	2.35e-05	0.000213	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ECHS1—stomach cancer	2.35e-05	0.000213	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—RHOA—stomach cancer	2.35e-05	0.000213	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FGFR2—stomach cancer	2.33e-05	0.000211	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TYMS—stomach cancer	2.33e-05	0.000211	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CAV1—stomach cancer	2.31e-05	0.000209	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HBEGF—stomach cancer	2.31e-05	0.000209	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOA1—stomach cancer	2.31e-05	0.000209	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTM1—stomach cancer	2.3e-05	0.000209	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SMAD4—stomach cancer	2.3e-05	0.000208	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL8—stomach cancer	2.27e-05	0.000206	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SREBF2—stomach cancer	2.27e-05	0.000206	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—RORA—stomach cancer	2.24e-05	0.000203	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—FADS1—stomach cancer	2.23e-05	0.000202	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TYMP—stomach cancer	2.23e-05	0.000202	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—FADS1—stomach cancer	2.21e-05	0.0002	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TYMP—stomach cancer	2.21e-05	0.0002	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6R—stomach cancer	2.2e-05	0.000199	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—RHOA—stomach cancer	2.19e-05	0.000198	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FYN—stomach cancer	2.18e-05	0.000197	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ERCC2—stomach cancer	2.17e-05	0.000196	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IRS2—stomach cancer	2.14e-05	0.000194	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADRB2—stomach cancer	2.13e-05	0.000193	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALDOB—stomach cancer	2.1e-05	0.00019	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PPP2R1A—stomach cancer	2.09e-05	0.000189	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SREBF2—stomach cancer	2.09e-05	0.000189	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CAV1—stomach cancer	2.07e-05	0.000188	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SREBF2—stomach cancer	2.07e-05	0.000188	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOA1—stomach cancer	2.07e-05	0.000187	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—RORA—stomach cancer	2.06e-05	0.000187	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL8—stomach cancer	2.06e-05	0.000187	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FGFR2—stomach cancer	2.05e-05	0.000185	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—RORA—stomach cancer	2.05e-05	0.000185	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—stomach cancer	2.04e-05	0.000184	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARG—stomach cancer	2.03e-05	0.000184	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—RHOA—stomach cancer	1.99e-05	0.00018	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.98e-05	0.00018	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.98e-05	0.000179	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRKCB—stomach cancer	1.97e-05	0.000179	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6ST—stomach cancer	1.96e-05	0.000178	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALOX5—stomach cancer	1.95e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SMAD4—stomach cancer	1.94e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALDOB—stomach cancer	1.93e-05	0.000175	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DPYD—stomach cancer	1.92e-05	0.000174	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL8—stomach cancer	1.92e-05	0.000174	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALDOB—stomach cancer	1.92e-05	0.000174	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APC—stomach cancer	1.89e-05	0.000171	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CAV1—stomach cancer	1.88e-05	0.00017	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IRS2—stomach cancer	1.87e-05	0.00017	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOA1—stomach cancer	1.87e-05	0.00017	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FYN—stomach cancer	1.84e-05	0.000167	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—stomach cancer	1.83e-05	0.000166	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CAV1—stomach cancer	1.82e-05	0.000165	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOA1—stomach cancer	1.81e-05	0.000164	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—MAPK3—stomach cancer	1.81e-05	0.000164	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.81e-05	0.000164	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.8e-05	0.000163	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALOX5—stomach cancer	1.8e-05	0.000163	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.79e-05	0.000163	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALOX5—stomach cancer	1.78e-05	0.000161	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DPYD—stomach cancer	1.77e-05	0.00016	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DPYD—stomach cancer	1.75e-05	0.000159	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6R—stomach cancer	1.75e-05	0.000159	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NOS3—stomach cancer	1.75e-05	0.000158	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL8—stomach cancer	1.74e-05	0.000158	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.74e-05	0.000158	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FGFR2—stomach cancer	1.73e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRKCB—stomach cancer	1.73e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6ST—stomach cancer	1.72e-05	0.000156	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—MAPK1—stomach cancer	1.72e-05	0.000156	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—EGFR—stomach cancer	1.72e-05	0.000156	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTT1—stomach cancer	1.7e-05	0.000154	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2A6—stomach cancer	1.68e-05	0.000152	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APC—stomach cancer	1.66e-05	0.00015	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARG—stomach cancer	1.65e-05	0.00015	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PIK3CA—stomach cancer	1.64e-05	0.000149	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SERPINE1—stomach cancer	1.64e-05	0.000149	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKR1C3—stomach cancer	1.63e-05	0.000148	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—KRAS—stomach cancer	1.62e-05	0.000147	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—stomach cancer	1.6e-05	0.000145	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ENO1—stomach cancer	1.59e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.59e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—MAPK3—stomach cancer	1.59e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS2—stomach cancer	1.58e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RHOA—stomach cancer	1.58e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—stomach cancer	1.57e-05	0.000142	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.57e-05	0.000142	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTT1—stomach cancer	1.56e-05	0.000142	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTT1—stomach cancer	1.55e-05	0.00014	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.55e-05	0.00014	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6R—stomach cancer	1.54e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CAV1—stomach cancer	1.54e-05	0.000139	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.53e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOA1—stomach cancer	1.53e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—MAPK1—stomach cancer	1.51e-05	0.000137	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—EGFR—stomach cancer	1.51e-05	0.000137	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.5e-05	0.000136	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CA—stomach cancer	1.49e-05	0.000135	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.49e-05	0.000135	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—stomach cancer	1.48e-05	0.000135	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ERBB2—stomach cancer	1.47e-05	0.000133	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ENO1—stomach cancer	1.47e-05	0.000133	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRKCB—stomach cancer	1.46e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6ST—stomach cancer	1.46e-05	0.000132	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ENO1—stomach cancer	1.45e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CA—stomach cancer	1.44e-05	0.000131	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SERPINE1—stomach cancer	1.44e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.43e-05	0.000129	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—KRAS—stomach cancer	1.42e-05	0.000129	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—stomach cancer	1.42e-05	0.000129	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CD44—stomach cancer	1.41e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APC—stomach cancer	1.4e-05	0.000127	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL8—stomach cancer	1.39e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RHOA—stomach cancer	1.39e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HRAS—stomach cancer	1.38e-05	0.000125	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—stomach cancer	1.37e-05	0.000124	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.37e-05	0.000124	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDKN1B—stomach cancer	1.36e-05	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—MAPK3—stomach cancer	1.34e-05	0.000121	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—stomach cancer	1.32e-05	0.00012	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CA—stomach cancer	1.31e-05	0.000119	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CD44—stomach cancer	1.3e-05	0.000118	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6R—stomach cancer	1.3e-05	0.000118	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—stomach cancer	1.3e-05	0.000118	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCND1—stomach cancer	1.3e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—JUN—stomach cancer	1.29e-05	0.000117	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CD44—stomach cancer	1.29e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ERBB2—stomach cancer	1.29e-05	0.000116	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—MAPK1—stomach cancer	1.27e-05	0.000115	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EGFR—stomach cancer	1.27e-05	0.000115	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—stomach cancer	1.26e-05	0.000114	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDKN1A—stomach cancer	1.25e-05	0.000113	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.25e-05	0.000113	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK8—stomach cancer	1.22e-05	0.000111	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL8—stomach cancer	1.22e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CA—stomach cancer	1.22e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SERPINE1—stomach cancer	1.22e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HRAS—stomach cancer	1.21e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—KRAS—stomach cancer	1.2e-05	0.000109	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.2e-05	0.000109	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDKN1B—stomach cancer	1.19e-05	0.000108	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTP1—stomach cancer	1.18e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RHOA—stomach cancer	1.17e-05	0.000106	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HMOX1—stomach cancer	1.16e-05	0.000105	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—stomach cancer	1.16e-05	0.000105	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—stomach cancer	1.16e-05	0.000105	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCND1—stomach cancer	1.14e-05	0.000103	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—JUN—stomach cancer	1.13e-05	0.000103	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—stomach cancer	1.13e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—stomach cancer	1.12e-05	0.000101	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CA—stomach cancer	1.11e-05	0.0001	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.11e-05	0.0001	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—stomach cancer	1.1e-05	9.99e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDKN1A—stomach cancer	1.1e-05	9.95e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TYMS—stomach cancer	1.1e-05	9.92e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.1e-05	9.92e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ERBB2—stomach cancer	1.09e-05	9.84e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTP1—stomach cancer	1.08e-05	9.82e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTM1—stomach cancer	1.08e-05	9.81e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTP1—stomach cancer	1.07e-05	9.73e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK8—stomach cancer	1.07e-05	9.71e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HMOX1—stomach cancer	1.07e-05	9.68e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK3—stomach cancer	1.07e-05	9.67e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HMOX1—stomach cancer	1.06e-05	9.6e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MYC—stomach cancer	1.04e-05	9.41e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL8—stomach cancer	1.03e-05	9.33e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HRAS—stomach cancer	1.02e-05	9.27e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ERCC2—stomach cancer	1.02e-05	9.22e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK1—stomach cancer	1.02e-05	9.21e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGFR—stomach cancer	1.02e-05	9.2e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TYMS—stomach cancer	1.01e-05	9.13e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN1B—stomach cancer	1.01e-05	9.11e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TYMS—stomach cancer	9.99e-06	9.05e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTM1—stomach cancer	9.96e-06	9.02e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—stomach cancer	9.9e-06	8.97e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTM1—stomach cancer	9.87e-06	8.94e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CA—stomach cancer	9.84e-06	8.91e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—stomach cancer	9.8e-06	8.88e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—stomach cancer	9.8e-06	8.87e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—KRAS—stomach cancer	9.6e-06	8.69e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCND1—stomach cancer	9.6e-06	8.69e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—JUN—stomach cancer	9.58e-06	8.68e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—stomach cancer	9.57e-06	8.67e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ERCC2—stomach cancer	9.37e-06	8.48e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK3—stomach cancer	9.36e-06	8.48e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—stomach cancer	9.32e-06	8.44e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ERCC2—stomach cancer	9.28e-06	8.41e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN1A—stomach cancer	9.28e-06	8.41e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MYC—stomach cancer	9.11e-06	8.25e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK8—stomach cancer	9.06e-06	8.21e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK1—stomach cancer	8.91e-06	8.07e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGFR—stomach cancer	8.91e-06	8.07e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAV1—stomach cancer	8.83e-06	8e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CA—stomach cancer	8.82e-06	7.99e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOA1—stomach cancer	8.81e-06	7.98e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—stomach cancer	8.8e-06	7.97e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—stomach cancer	8.73e-06	7.91e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—stomach cancer	8.53e-06	7.73e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.43e-06	7.64e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KRAS—stomach cancer	8.42e-06	7.62e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—stomach cancer	8.37e-06	7.58e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—stomach cancer	8.28e-06	7.5e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HRAS—stomach cancer	8.16e-06	7.39e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAV1—stomach cancer	8.12e-06	7.36e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOA1—stomach cancer	8.1e-06	7.34e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAV1—stomach cancer	8.05e-06	7.29e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOA1—stomach cancer	8.03e-06	7.28e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CA—stomach cancer	7.99e-06	7.24e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK3—stomach cancer	7.91e-06	7.17e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—stomach cancer	7.81e-06	7.07e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—stomach cancer	7.76e-06	7.03e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	7.73e-06	7e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MYC—stomach cancer	7.7e-06	6.97e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.69e-06	6.97e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK1—stomach cancer	7.53e-06	6.82e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGFR—stomach cancer	7.53e-06	6.82e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—stomach cancer	7.48e-06	6.78e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HRAS—stomach cancer	7.15e-06	6.48e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—stomach cancer	7.14e-06	6.47e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KRAS—stomach cancer	7.11e-06	6.44e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—stomach cancer	7.08e-06	6.41e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—stomach cancer	6.98e-06	6.32e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—stomach cancer	6.85e-06	6.2e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—stomach cancer	6.68e-06	6.05e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	6.53e-06	5.92e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—stomach cancer	6.42e-06	5.81e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—stomach cancer	6.36e-06	5.76e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—stomach cancer	6.32e-06	5.73e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—stomach cancer	6.14e-06	5.56e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—stomach cancer	6.11e-06	5.53e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—stomach cancer	6.09e-06	5.51e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HRAS—stomach cancer	6.05e-06	5.48e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—stomach cancer	5.79e-06	5.24e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—stomach cancer	5.62e-06	5.09e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—stomach cancer	5.57e-06	5.04e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CA—stomach cancer	3.76e-06	3.4e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.45e-06	3.13e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CA—stomach cancer	3.43e-06	3.1e-05	CbGpPWpGaD
